New Horizon Health Limited provided group earnings guidance for the year ended December 31, 2022. The total revenue of the Group for the year ended December 31, 2022 is expected to be within the range of RMB 750.5 million to RMB 782.5 million, representing an increase in the range of 252.7% to 267.7% from approximately RMB 212.8 million for the year ended December 31, 2021.